Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genomic profiling guides the choice of molecular targeted therapy of pancreatic cancer.

Cancer letters - 10 Jul 2015

Frank Thomas S, Sun Xiaotian, Zhang Yuqing, Yang Jingxuan, Fisher William E, Gingras Marie-Claude, Li Min

Abstract excerpt

Pancreatic cancer has the worst five-year survival rate of all malignancies due to its aggressive progression and resistance to therapy. Current therapies are limited to gemcitabine-based chemotherapeutics, surgery, and radiation. The current trend toward "personalized genomic medicine" has the potential to improve the treatment options for pancreatic cancer. Gene identification and genetic alterations like...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Agents
Share to Drug Resistance, Neoplasm

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Molecular Targeted Therapy

Share to Pancreatic Neoplasms

Share to Patient Selection

Share to Pharmacogenetics

Share to Precision Medicine

Share to Predictive Value of Tests

Source

Open in PubMed Open full text

Identifiers

PMID: 25890222
DOI: 10.1016/j.canlet.2015.04.009
PMCID: PMC4451193

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genomic profiling guides the choice of molecular targeted therapy of pancreatic cancer.PMID 25890222Read ↗

Genetic and molecular alterations in pancreatic cancer: Implications for personalized medicineSemantic proximity Read ↗

Genomic Variations in Pancreatic Cancer and Potential Opportunities for Development of New Approaches for Diagnosis and Treatment.Semantic proximity Read ↗

Pancreatic Cancer Genomes: Implications for Clinical Management and Therapeutic Development.Semantic proximity Read ↗

Molecular and Phenotypic Profiling for Precision Medicine in Pancreatic Cancer: Current Advances and Future PerspectivesSemantic proximity Read ↗

Pancreatic cancer genomics.Semantic proximity Read ↗

Pancreatic cancer biomarkers: A pathway to advance in personalized treatment selection.Semantic proximity Read ↗

Genomic alterations in pancreatic cancer and their relevance to therapySemantic proximity Read ↗

Toward the goal of personalized therapy in pancreatic cancer by targeting the molecular phenotype.Semantic proximity Read ↗

Improving the prognosis of pancreatic cancer: insights from epidemiology, genomic alterations, and therapeutic challenges.Semantic proximity Read ↗

Genetic landscape of pancreatic cancer: a narrative review.Semantic proximity Read ↗

Molecular classification as prognostic factor and guide for treatment decision of pancreatic cancer.Semantic proximity Read ↗

Genomic profiling in pancreatic ductal adenocarcinoma and a pathway towards therapy individualization: A scoping reviewSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.